Evidence map›Paper›PMID 20014107›Full record

ArticleBiotechnology progress

Active and inactive metabolic pathways in tumor spheroids: determination by GC-MS.

Michael G Hunnewell, Neil S Forbes

Abstract read
In one paragraph

Article in Biotechnology progress. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.2field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Michael G HunnewellDept. of Chemical Engineering, University of Massachusetts Amherst, Amherst, MA 01003, USA.
Neil S Forbes
University of Massachusetts Amherst · US

Funding

Engineering Salmonella to be a targeted intratumoral anti-cancer therapeuticR01CA120825 · NCI · UNIVERSITY OF MASSACHUSETTS AMHERST · PI FORBES, NEIL S. · 2008 to 2011
$1.2M
Microelectrode oxygenation control of tumor necrosisR21CA112335 · NCI · UNIVERSITY OF MASSACHUSETTS AMHERST · PI FORBES, NEIL S · 2005 to 2006
$332k
NCI NIH HHS 1R01CA120825-01A1NCI NIH HHS 1R21CA112335-01ANCI NIH HHS R01 CA120825NCI NIH HHS R21 CA112335
6 · The paper itself

Abstract

Active metabolic pathways in three-dimensional cancer-cell cultures are potential chemotherapeutic targets that would be effective throughout tumors. Chaotic vasculature creates cellular regions in tumors with distinct metabolic behavior that are only present in aggregate cell masses. To quantify cancer cell metabolism, transformed mouse fibroblasts were grown as spheroids and fed isotopically labeled culture medium. Metabolite uptake and production rates were measured as functions of time. Gas chromatography-mass spectrometry was used to quantify the extent of labeling on amino acids present in cytoplasmic extracts. The labeling pattern identified several active and inactive metabolic pathways: Glutaminolysis was found to be active, and malic enzyme and gluconeogenesis were inactive. Transformed cells in spheroids were also found to actively synthesize serine, cysteine, alanine, aspartate, glutamate, and proline; and not synthesize glutamine. The activities of these pathways suggest that cancer cells consume glutamine for biosynthesis and not to provide cellular energy. Determining active metabolic pathways indicates how cells direct carbon flow and may lead to the discovery of novel molecular targets for anticancer therapy.

Indexed as

GluconeogenesisPentose Phosphate PathwayAnimalsCell ProliferationFibroblastsGas Chromatography-Mass SpectrometryGlutamic AcidIsotope LabelingMalate DehydrogenaseMiceNeoplasms, ExperimentalParticle SizeSpheroids, CellularTricarboxylic AcidsGlutamic AcidMalate DehydrogenaseTricarboxylic Acids

Identifiers

PMID20014107
PMCPMC4972351
OpenAlexW2125693385

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.